High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma (Q38926293)

7 September 2017

title

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma (English)

1 reference

7 September 2017

Arno Velds

8

0 references

Michael Stratton

12

object named as

Michael R Stratton

1 reference

7 September 2017

14

Hergen Spits

1 reference

7 September 2017

7

Sam Behjati

1 reference

7 September 2017

13

John B A G Haanen

1 reference

7 September 2017

Sjoerd H van der Burg

15

object named as

Sjoerd H van der Burg

1 reference

7 September 2017

Carsten Linnemann

1

1 reference

7 September 2017

Marit M van Buuren

2

1 reference

7 September 2017

Laura Bies

3

1 reference

7 September 2017

Els M E Verdegaal

4

1 reference

7 September 2017

Remko Schotte

5

1 reference

7 September 2017

Jorg J A Calis

6

1 reference

7 September 2017

Henk Hilkmann

9

1 reference

7 September 2017

Dris El Atmioui

10

1 reference

7 September 2017

Marten Visser

11

1 reference

7 September 2017

Ton N M Schumacher

16

1 reference

7 September 2017

language of work or name

English

0 references

publication date

22 December 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

21

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

81-85

1 reference

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

7 September 2017

cites work

1 reference

12 December 2020

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

1 reference

12 December 2020

Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions.

1 reference

12 December 2020

Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes

1 reference

12 December 2020

Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy

1 reference

12 December 2020

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

1 reference

12 December 2020

A very high level of crossreactivity is an essential feature of the T-cell receptor

1 reference

12 December 2020

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

12 December 2020

Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming

1 reference

12 December 2020

Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients

1 reference

12 December 2020

TopHat: discovering splice junctions with RNA-Seq

1 reference

12 December 2020

Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression.

1 reference

12 December 2020

MiTCR: software for T-cell receptor sequencing data analysis.

1 reference

12 December 2020

Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigens

1 reference

12 December 2020

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

1 reference

12 December 2020

Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.

1 reference

12 December 2020

The Sequence Alignment/Map format and SAMtools

1 reference

12 December 2020

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

1 reference

12 December 2020

Fast and accurate long-read alignment with Burrows-Wheeler transform

1 reference

12 December 2020

Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts

1 reference

12 December 2020

Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors

1 reference

12 December 2020

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

1 reference

12 December 2020

Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia

1 reference

12 December 2020

The regulatory landscape for actively personalized cancer immunotherapies

1 reference

12 December 2020

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha

1 reference

12 December 2020

TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.

1 reference

12 December 2020

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

1 reference

12 December 2020

Signatures of mutational processes in human cancer

1 reference

12 December 2020

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma

1 reference

12 December 2020

Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter

1 reference

12 December 2020

Cancer genome landscapes

1 reference

12 December 2020

Fast and accurate short read alignment with Burrows-Wheeler transform

1 reference

12 December 2020

Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire

1 reference

12 December 2020

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.

1 reference

12 December 2020

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.3773

1 reference

7 September 2017

1 reference